These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2390922)

  • 1. Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.
    Jansen JB; de Jong AJ; Singer MV; Niebel W; Rovati LC; Lamers CB
    Dig Dis Sci; 1990 Sep; 35(9):1073-7. PubMed ID: 2390922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic stimulation of pancreatic polypeptide release by a meal, bombesin, neurotensin, tetragastrin, cholecystokinin, and cerulein.
    Modlin IM; Jaffe BM; Albert D; Sank A; Materia A; Crochelt R
    J Surg Res; 1983 Aug; 35(2):113-8. PubMed ID: 6310229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
    de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
    Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin is a regulator of intestinal phase-stimulated PP release.
    Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A
    Regul Pept; 1990 Sep; 30(2):105-11. PubMed ID: 2274676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
    Jansen JB; Jebbink MC; Douglas BR; Lamers CB
    Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli.
    Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Hladij M
    Gastroenterology; 1988 Apr; 94(4):1014-23. PubMed ID: 3345871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
    Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
    Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
    Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
    Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons.
    Lieverse RJ; Masclee AA; Jansen JB; Lamers CB
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):123-7. PubMed ID: 8148926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
    Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
    Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
    Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
    Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic role of cholecystokinin in the intestinal phase of pancreatic polypeptide release.
    Fried GM; Ogden WD; Greeley GH; Thompson JC
    Ann Surg; 1984 Nov; 200(5):600-4. PubMed ID: 6486910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nicotine on basal and bombesin stimulated canine plasma levels of gastrin, cholecystokinin and pancreatic polypeptide.
    Chowdhury P; Inoue K; Rayford PL
    Peptides; 1985; 6(1):127-32. PubMed ID: 3991359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK receptors in release of pancreatic polypeptide (PP) in dogs.
    Konturek SJ; Konturek P; Bielański W; Szewczyk K
    Dig Dis Sci; 1989 Jun; 34(6):849-56. PubMed ID: 2721318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
    Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
    Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.